Patients with diabetic nephropathy face an increased risk of dying due to cardiac causes. The aim of this follow-up trial was to describe the association between the length of the QT interval, as a marker of myocardial electrical stability, and the risk of death in insulin-dependent (IDDM) diabetic patients with overt diabetic nephropathy. A consecutive sample of 85 IDDM patients with overt diabetic nephropathy (i. e. persistent proteinuria ≥ 500 mg/24 h) were followed-up until death or for a period of 5–13 years. QT intervals were measured once at baseline in a 12-lead ECG and corrected for heart rate (QTc). During the follow-up period 33 patients (39%) died. In the Cox proportional hazards model independent predictors of death were age (p=0.0007), the length of the maximum QTc period (p=0.0049), presence of autonomic neuropathy (p=0.0068), diabetes duration (p=0.0163) and RR variation (p=0.0395). In conclusion, in nephropathic IDDM patients QT prolongation is associated with an increased mortality risk which is independent of the presence of autonomic neuropathy. Further studies are needed to determine whether this risk might be reduced by therapeutic interventions.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Insulin-dependent diabetes mellitus
QT intervals corrected for heart rate
Borch-Johnsen K, Kreiner S, Deckert T (1986) Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia 29: 767–772
Borch-Johnson K, Kreiner S (1987) Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ 294: 1651–1654
Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet I:601–603
Page MMcB, Watkins PJ (1978) Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet I:14–16
Pont A, Rushing JL, Kelsey T, Jacobs L (1978) Cardiorespiratory arrest in diabetic neuropathy. Lancet I:386–387
Garcia-Bunuel L (1978) Cardiorespiratory arrest in diabetic neuropathy. Lancet I:935–936
Srinivasan G, Sanders G (1978) Cardiorespiratory arrest in diabetes. Lancet I:504–505
Ong JJC, Sarma JSM, Venkataraman K, Levin SR, Singh BN (1993) Cardiac rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J 125: 744–752
Bexton RS, Vallin HO, Camm AJ (1986) Diurnal variation of the QT interval-influence of the automatic nervous system. Br Heart 55: 253–258
Browne KF, Zipes DP, Heger JJ, Prystowsky EN (1982) Influence of the autonomic nervous system on the QT interval in man. Am J Cardiol 50: 1099–1103
Ahnve S, Vallin H (1982) Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 65: 435–439
Vlay SC, Mallis GI, Brown EJ, Cohn PF (1984) Documented sudden cardiac death in prolonged Q-T syndrome. Arch Intern Med 144: 833–834
Barr CS, Naas A, Freeman M, Lang C, Struthers AD (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343: 327–329
Jensen T, Borch-Johnsen K, Koefoed-Enevoldsen A, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30: 144–148
MØlgaard H, Christensen PD, Hermansen K, SØrensen KE, Christensen CK, Mogensen CE (1994) Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus? Diabetologia 37: 788–796
Puddu PE, Bourassa MG (1986) Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiology 19: 203–211
Bellavere F, Ferri M, Guarini et al. (1988) Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death. Br Heart J 59: 379–383
Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF (1991) Autonomic neuropathy, QT interval lenthening, and unexpected deaths in male diabetic patients. Diabetologia 34: 182–185
Jermendy G, Tóth L, Vörös P, Koltai MZ, Pogátsa G (1991) Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients. Acta Cardiol 46: 189–200
MØlgaard H, Christensen PD, SØrensen KE, Christensen CK, Mogensen CE (1992) Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM. Diabetes 41: 812–817
Internationale Klassifikation der Krankheiten (ICD) (1993) 9th Revision, 2nd edn. Kohlhammer, Cologne
Day CP, James OFW, Butler TJ, Campbell RWF (1993) QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 341: 1423–1428
Sawicki PT, Heinemann L, Berger M (1989) Comparison of methods for determination of microalbuminuria in diabetic patients. Diabet Med 6: 412–415
Ewing DJ (1984) Cardiac autonomic neuropathy. In: Jarrett J (ed) Diabetes and heart disease. Elsevier, New York, pp 99–132
Cox DR (1972) Regression models and life tables (with discussion). J R Statist Soc B 34: 187–220
SAS (1987) SAS/STAT guide for personal computers. Version 6 edition. SAS Institute Inc., Cary, N. C.
SAS (1988) SAS technical report P-179, additional SAS/STAT procedures. Release 6.03. SAS Institute Inc., Cary, N.C.
SAS (1991) SAS technical report P-217, SAS/STAT software. The PHREG procedure, version 6. SAS Institute Inc., Cary, N.C.
Parving HH, Hommel E (1989) Prognosis in diabetic nephropathy. BMJ 299: 230–233
Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T (1989) Improved survival in patients with diabetic nephropathy. Diabetologia 32: 884–886
MØlgaard H, Mickley H, Pless P, Bjerregaard P, MØller M (1993) Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol 71: 1357–1359
Wilkstrand J, Kendall M (1992) The role of beta receptor blockade in preventing sudden death. Eur Heart J 13[Suppl D]:111–120
Kjekshus J, Glipin E, Cali G, Blackey AR, Henning H, Ross J Jr (1990) Diabetic patients and beta-blockers after myocardial infarction. Eur Heart J 11: 43–50
About this article
Cite this article
Sawicki, P.T., DÄhne, R., Bender, R. et al. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia 39, 77–81 (1996). https://doi.org/10.1007/BF00400416
- Diabetic nephropathy
- diabetic autonomic neuropathy
- QT interval